Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-102146
Filing Date
2024-09-23
Accepted
2024-09-23 18:14:19
Documents
1
Period of Report
2024-09-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2424588-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2424588-1_4seq1.xml 4 21944
  Complete submission text file 0001104659-24-102146.txt   23533
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Issuer) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 CAMPUS BOULEVARD SUITE 100 NEWTOWN SQUARE PA 19073
Business Address
LaChapelle Robin (Reporting) CIK: 0002009136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41929 | Film No.: 241317238